Intubation; Difficult or Failed
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Mission TherapeuticsUK - Cambridge
1 programHEAVEN CRITERIA vs Modified LEMON Score for Predicting Difficult IntubationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Mission TherapeuticsHEAVEN CRITERIA vs Modified LEMON Score for Predicting Difficult Intubation
Clinical Trials (1)
Total enrollment: 192 patients across 1 trials
NCT05954533Mission TherapeuticsHEAVEN CRITERIA vs Modified LEMON Score for Predicting Difficult Intubation
HEAVEN CRITERIA vs Modified LEMON Score for Predicting Difficult Intubation
Start: Jul 2022Est. completion: Jul 2024192 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 192 patients
1 companies competing in this space